Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments
Farzin Zobdeh, Aziza ben Kraiem, Misty M. Attwood, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 23, pp. 4588-4607
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Rational approach to migraine attacks relief
Г. Р. Табеева
Neurology neuropsychiatry Psychosomatics (2025) Vol. 17, Iss. 2, pp. 100-106
Open Access
Advancing a generalizable model for migraine prediction: Analysis of filtering techniques on physiological signals
Viroslava Kapustynska, Vytautas Abromavičius, Artūras Serackis, et al.
Technology and Health Care (2025)
Closed Access
Pharmacogenetics in Primary Headache Disorders
Irina I. Belyaeva, Anna G. Subbotina, Иван Иванович Еременко, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 17
Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years
David Kernick, Nazanin Kondori, Andrew Pain, et al.
BMC Primary Care (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review
Piero Barbanti, Gianni Allais, Sabina Cevoli, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 319-346
Open Access | Times Cited: 3
Simultaneous Estimation of Zolmitriptan and Sumatriptan Succinate in Pure and Synthetic Mixture Using UV Spectrophotometer
Rajashekar Spoorthi, Veeresh Prabhakar Veerapur, Devi Reddy Prashanthi, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2024) Vol. 14, Iss. 1, pp. 1-7
Closed Access | Times Cited: 3
Bipartite Activation of Sensory Neurons by a TRPA1 Agonist Allyl Isothiocyanate Is Reflected by Complex Ca2+ Influx and CGRP Release Patterns: Enhancement by NGF and Inhibition with VAMP and SNAP-25 Cleaving Botulinum Neurotoxins
Mariia Belinskaia, Jiafu Wang, Seshu Kumar Kaza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1338-1338
Open Access | Times Cited: 7
Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era
Eleonora Rollo, Marina Romozzi, Catello Vollono, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 8, pp. 1767-1785
Open Access | Times Cited: 12
Migraine and Its Treatment from the Medicinal Chemistry Perspective
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 951-966
Open Access | Times Cited: 2
Genistein mitigates nitroglycerine-induced migraine: modulation of nitric oxide-mediated vasodilation and oxidative stress
Sarika Chaudhary, Lovedeep Singh, Manjot Kaur, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 821-831
Closed Access | Times Cited: 2
Safety profile of lasmiditan: a retrospective post-marketing pharmacovigilance study based on the real-world data of FAERS database
Xiaochen Wan, Shuohan Zhang, Cheng Jiang, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 2
Acupoints for Headache with Blood Stasis Syndrome: a Literature Study Based on Data Mining Technology
J.Z. Shi, Tingting Li, Huiting Yang, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 2455-2471
Open Access | Times Cited: 2
Currently Available Interventions for the Management of Migraine Pain
Rakesh K. Singh, Shivam Kumar Pandey, Shreya Singh, et al.
(2024), pp. 191-227
Closed Access | Times Cited: 2
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank
Claudia Pisanu, Nike Zoe Welander, Gull Rukh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112234-112234
Open Access | Times Cited: 11
Documento de consenso de la Sociedad Española de Neurología (SEN), Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atención Primaria (SEMERGEN) y Asociación Española de Migraña y Cefalea (AEMICE) sobre el tratamiento de la migraña
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access | Times Cited: 1
Animal Models of Chronic Migraine: From the Bench to Therapy
Wei Zhang, Yun Zhang, Han Wang, et al.
Current Pain and Headache Reports (2024) Vol. 28, Iss. 11, pp. 1123-1133
Closed Access | Times Cited: 1
A Retrospective Analysis of Disease Epidemiology, Comorbidity Burden, Treatment Patterns, and Healthcare Resource Utilization of Migraine in the United Arab Emirates
Alessandro Terruzzi, Abubaker Almadani, Suhail Alrukn, et al.
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1235-1255
Open Access | Times Cited: 1
The effects of antiseizure medications on comorbidities
Fergus Rugg‐Gunn, Philip N. Patsalos
Oxford University Press eBooks (2024), pp. 29-54
Closed Access | Times Cited: 1
Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center
Lucas Séjournet, Thibaud Mathis, V Vermot-Desroches, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1183-1183
Open Access | Times Cited: 1
Novel Treatment Approaches for the Management of Migraine Pain
Harish Selvaraj, Suhashini Shanmuganathan, Jean Sophy Roy, et al.
(2024), pp. 161-189
Closed Access | Times Cited: 1
Cost of illness and labour market disaffiliation among patients with migraine discontinuing triptan treatment: A Danish nationwide register study from 1995 to 2021
Messoud Ashina, Timothy J. Steiner, Jakob Møller Hansen, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 1
Use of aromatherapy for Migraine pain relief
Yasmine Askeur, Mohammed Adil Selka, D Kamel
Current Perspectives on Medicinal and Aromatic Plants (CUPMAP) (2024)
Open Access | Times Cited: 1
Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system
Bing Cao, Shanshan Gu, Zhisen Shen, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 3, pp. 297-303
Closed Access | Times Cited: 3
Neurovascular Compression-Induced Intracranial Allodynia May Be the True Nature of Migraine Headache: an Interpretative Review
Valdas Macionis
Current Pain and Headache Reports (2023) Vol. 27, Iss. 11, pp. 775-791
Closed Access | Times Cited: 2
How does a physician decide which pharmacotherapeutic option to select for acute migraine attacks?
Elena P. Calandre, Mahmoud Slim, Fernando Rico‐Villademoros
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 10, pp. 1129-1133
Open Access | Times Cited: 4

Scroll to top